Source: Annual Congress 2004 - Management of lung cancer and innovative therapies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. T. Lee, C. G. Yoo, Y. W. Kim, S. K. Han, Y. S. Shim, D. P. Carbone (Seongnam, Seoul, South Korea; Nashville, United States Of America). Combination gene therapy with conditionally replicating adenovirus and adenovirus-p27 of lung cancer. Eur Respir J 2004; 24: Suppl. 48, 1522

Member's Comments

No comment yet.

Related content which might interest you: Targeted therapy for lung cancer Source: Eur Respir J 2015; 46: 1239-1241 Year: 2015 MIP-3alpha gene therapy combined with localized radiation therapy boost anti-tumor immunity in a murine model of lung carcinoma Source: Eur Respir J 2005; 26: Suppl. 49, 328s Year: 2005 Adenovirus-mediated interferon-β gene therapy combined with radiotherapy synergistically inhibits lung tumor growth in mice Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004 Successful targeted therapy of advanced lung cancer Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session Year: 2013 Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 199s Year: 2003 Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis Source: Eur Respir J 2002; 20: 703-709 Year: 2002 Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations Source: Eur Respir J 2015; 46: 19-21 Year: 2015 Second-line combination therapies in nonsmall cell lung cancer without known driver mutations Source: Eur Respir Rev 2015; 24: 582-593 Year: 2015 Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002 CAR T-cell therapy for lung cancer Source: International Congress 2017 – A novel approach to lung cancer Year: 2017 Advances in target therapy in lung cancer Source: Eur Respir Rev 2015; 24: 23-29 Year: 2015 Advances in target therapy for lung cancer Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I Year: 2014 Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006 Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 Survival prognosis and target therapy best response in adenocarcinoma lung cancer pts with mutation EGFR gene Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 The effect of new drug-resistance antisense gene on multidrug resistance mechanism of drug-resistant human small cell lung cancer cells Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007